"The F.D.A. has approved six commercial CAR-T products. Cancer specialists said the treatments have saved the lives of thousands of patients with blood cancers. Even if there is a causal link between the treatments and a small risk of a new blood cancer, the regulators said on Tuesday, the benefits of the treatment outweigh the risks. That sentiment was echoed by doctors involved in cancer treatment."
#immunology #immunotherapy #CARTcells

https://www.nytimes.com/2023/11/28/health/fda-car-t-blood-cancer.html